Answers are grounded in this paper and cite their sources.
Objective: Based on the gut–brain axis theory, this study aimed to investigate the effects of electroacupuncture (EA) at Baihui (GV20) and Zusanli (ST36) on anxiety-like behaviors, neurotransmitters, inflammatory factors, intestinal neuropeptides, and gut microbiota in rats with generalized anxiety disorder (GAD) induced by chronic restraint stress (CRS). The study sought to evaluate the therapeutic effects of EA on GAD, explore its potential underlying mechanisms, and provide a scientific basis and novel therapeutic insights for the use of EA in GAD treatment. Methods: Forty male specific pathogen-free (SPF) Sprague–Dawley (SD) rats were randomly assigned to four groups: a control group, a model group, an EA group, and a drug treatment group. A rat model of GAD was established using CRS. Rats in the EA group received EA at Baihui (GV20) and Zusanli (ST36) (1 mA, 2 Hz, 15 min) 1 h before daily CRS exposure for three consecutive weeks. Rats in the drug treatment group received paroxetine hydrochloride (20 mg/kg) by oral gavage 1 h before daily CRS exposure for three consecutive weeks. Anxiety-like behaviors were assessed using the elevated plus maze (EPM) and Open Field Test (OFT). Enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of 5-hydroxytryptamine (5-HT), γ-aminobutyric acid (GABA), and vasoactive intestinal peptide (VIP) in intestinal tissues, as well as serum levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). Western blotting was performed to determine the protein expression levels of γ-aminobutyric acid type A receptor subunit α1 (GABRA1) and brain-derived neurotrophic factor (BDNF) in the hippocampus. Gut microbiota composition was analyzed using 16S rDNA gene sequencing, followed by correlation analyses between microbial taxa and the measured biological parameters. Results: Compared with the control group, CRS-exposed rats exhibited pronounced anxiety-like behaviors, accompanied by decreased levels of 5-HT and GABA in intestinal tissues and reduced hippocampal expression of GABRA1 and BDNF, as well as increased serum levels of IL-6 and TNF-α and elevated intestinal VIP levels. Compared with the model group, EA significantly alleviated anxiety-like behaviors, increased 5-HT and GABA levels and GABRA1 and BDNF expression, and decreased IL-6, TNF-α, and VIP levels. 16S rDNA gene sequencing revealed that EA was associated with alterations in gut microbiota composition and richness. Correlation analyses identified associations between Duncaniella and members of the family Erysipelotrichaceae and selected neurotransmitter and inflammatory markers. Conclusions: 1. EA increased intestinal 5-HT and GABA levels, upregulated hippocampal GABRA1 and BDNF expression, reduced serum IL-6 and TNF-α levels, and modulated abnormal intestinal VIP levels in GAD model rats. These findings suggest that EA may exert anxiolytic effects by regulating neurotransmitter balance, promoting neuroplasticity, and suppressing inflammatory responses. 2. EA may exert its anxiolytic effects through the gut–brain axis by modulating gut microbial homeostasis and influencing neurotransmitter regulation and inflammatory responses.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: